Baseline immune signature score of Tregs × HLA-DRCD4 T cells × PD1CD8 T cells predicts outcome to immunotherapy in cancer patients.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationFrontiers in immunology
View this publicationJournal of cancer research and clinical oncology
View this publicationAnnals of hematology
View this publicationFrontiers in neurology
View this publicationJournal for immunotherapy of cancer
View this publicationInternational journal of molecular sciences
View this publicationRadiology
View this publicationJournal of cancer research and clinical oncology
View this publicationClinical case reports
View this publication